Eterna Therapeutics Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Eterna Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Eterna Therapeutics Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -1.02 USD/shares, a 20% decline year-over-year.
  • Eterna Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -4.42 USD/shares, a 16.8% increase year-over-year.
  • Eterna Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -4.08 USD/shares, a 49.4% increase from 2022.
  • Eterna Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -8.06 USD/shares, a 85.8% increase from 2021.
  • Eterna Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -56.6 USD/shares, a 13707% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4 +$3.98 +49.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$8 +$48.60 +85.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$57 -$56 -13707% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.